Vous n'êtes pas connecté
Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. today announced that the Japanese Ministry of Health, Labour and Welfare has approved the AmoyDx® Pan Lung Cancer PCR Panel
Highlights: CfDNA offers a non-invasive way to detect and monitor diseases like cancer and genetic conditions
Prime Minister Phạm Minh Chính urged Mitsui & Co., Ltd of Japan to accelerate the implementation of the Block B gas-electricity project and expand...
The nuclear medicine industry is poised for significant growth in the near future, driven by the increasing incidence of cancer and chronic diseases...
The holder of the throne of the world's most powerful supercomputer is held by Frontier with processing capabilities reaching the level of exaFLOPS....
medlinkUltrasound/medlink is set to be an even more potent diagnostic tool for liver illness, cancer, and other diseases, owing to new technology...
What is circulating cell-free DNA, and how can it change healthcare? Discover how cfDNA offers non-invasive insights for cancer, prenatal care, and...
Harneys advised Mercuria Investment Co. Ltd. in relation to the successful closing of Japan Industry Revitalization and Innovation L.P., a Cayman...
Harneys advised Mercuria Investment Co. Ltd. in relation to the successful closing of Japan Industry Revitalization and Innovation L.P., a Cayman...